[LGND] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
06-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -130.34%
YoY- 56.06%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 84,675 55,150 69,990 41,848 41,420 33,161 27,003 114.38%
PBT 33,301 5,764 3,370 -11,612 28,119 -30,415 -8,175 -
Tax 2,576 -12,342 -2,391 -4,911 6,033 -6,284 -810 -
NP 30,725 18,106 5,761 -6,701 22,086 -24,131 -7,365 -
Tax Rate -7.74% 214.12% 70.95% - -21.46% - - -
Total Cost 53,950 37,044 64,229 48,549 19,334 57,292 34,368 35.10%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 36.29 32.83 8.23 -16.01 53.32 -72.77 -27.27 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS 1.84 1.10 0.36 -0.42 1.38 -1.46 -0.43 -
EPS Diluted 1.79 1.05 0.35 -0.42 1.32 -1.46 -0.43 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.